Navigation Links
5-bromo-2'-deoxyuridine (BrdU) from Molecular Probes (Invitrogen)

Products5-bromo-2'-deoxyuridine (BrdU) from Molecular Probes (Invitrogen)
Company Molecular Probes (Invitrogen)
Item 5-bromo-2'-deoxyuridine (BrdU)
Price 
Description 5-bromo-2'-deoxyuridine (BrdU)

Cell Biology
Cell Proliferation
Bromodeoxyuridine (BrdU) and Related Products

Info Molecular Probes (Invitrogen)Molecular Probes (Invitrogen)
PO Box 22010
Eugene, OR 97402-0469

Call Molecular Probes (Invitrogen) to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-541-359-2658
Customer Service: 1-541-465-8300
Fax Number: 1-541-344-6504
Web Site: http://probes.invitrogen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Cleland’s Reagent, Molecular Biology Grade from Calbiochem
2. SYBR Green II RNA gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)
3. SYBR Green II RNA gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)
4. SYBR Green II RNA gel stain*10,000X concentrate in DMSO**special packaging* from Molecular Probes (Invitrogen)
5. AquaMax DW4 from Molecular Devices
6. GenePix Pro Microarray Image Analysis Software from Molecular Devices
7. adenosine 5-O-(3-thiotriphosphate), BODIPY FL conjugated/tagged from Molecular Probes (Invitrogen)
8. Acuity Enterprise Microarray Informatics Software from Molecular Devices
9. SlowFade Antifade Kit from Molecular Probes (Invitrogen)
10. SYBR Green I nucleic acid gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)
11. SYBR Green I nucleic acid gel stain*10,000X concentrate in DMSO**special packaging* from Molecular Probes (Invitrogen)
... Reagent , 2 x 50 ml 10X TBST Wash ... 0.2 ml BL21 glycerol stock , 0.2 ml BLT5403 ... 1010 pfu T7Select Positive Control Lysate , 1010 ... HRP Conjugate , 2 ml T7Select S-protein , ...
...
Carbonate-Bicarbonate Buffer Capsules. For use in coating ELISA plates. Dissolve contents of 1 capsule in 100 ml deionized water to yield 0.05 M carbonate-bicarbonate buffer, pH 9.6....
Immunogen: Synthetic peptide: S(399) P W S E L E F Q F P D D K D P V W E F(418) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products:
(Date:12/14/2009)... The most comprehensive study to date of the ... appendages may provide important clues to how similar regeneration ... the School of Science at Indiana University-Purdue University Indianapolis ... amputated limbs of axolotls, a type of salamander that ... any level of amputation, with the hope that this ...
(Date:12/14/2009)... feature of humans. That,s until examples of tool use came ... of other mammals. Now, a report in the December 14th ... adds an octopus to the growing list of tool users. ... that the researchers call stilt walking. In it, the soft-bodied ... its eight arms rigid, and raises the whole assembly to ...
(Date:12/14/2009)... preventing some of the stresses of open surgery on the ... organ dysfunction. Laparoscopy is a type of surgery in the ... By adding another gas to the carbon dioxide used to ... Medical Center have found they can preserve more normal blood ... (ENO) helped to open blood vessels and keep blood flowing, ...
Breaking Biology News(10 mins):IUPUI researchers tackle protein mechanisms behind limb regeneration 2Tool use in an invertebrate: The coconut-carrying octopus 2Gas improves blood flow and organ status during minimally invasive surgery 2Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 1Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 2Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 3Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 4Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 5Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 6Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 7Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 8Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 9Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 10Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 11Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 12Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 13Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 14Dr James OConnell Named J H Kanter Prize Laureate 54148 1Dr James OConnell Named J H Kanter Prize Laureate 54148 2Dr James OConnell Named J H Kanter Prize Laureate 54148 3German District Court Rules in Smith 26 Nephews Favor in Patent Infringement Case 54146 1German District Court Rules in Smith 26 Nephews Favor in Patent Infringement Case 54146 2German District Court Rules in Smith 26 Nephews Favor in Patent Infringement Case 54146 3
... a violin to produce strong, elegant notes, researchers at ... outside of the body,s killer immune system cells which ... cells in superb infection- and disease-fighting condition. , In ... Immunology , the researchers describe their discovery of seven ...
... The Journal of Experimental Biology are pleased ... of Sydney is the winner of this year,s JEB ... 28th November in The Journal of Experimental Biology ... the contribution of an outstanding young scientist to an ...
... differentiations in the metabolic make-up of the human ... in the open-access journal PLoS Genetics . ... Karsten Suhre, has conducted a genome-wide association study ... in the breakdown of fats. The resulting differences ...
Other Biology News:Wistar scientists find key to keeping killer T cells in prime shape for fighting infection, cancer 2Wistar scientists find key to keeping killer T cells in prime shape for fighting infection, cancer 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 3Study identifies genetic variants giving rise to differences in metabolism 2
(Date:12/10/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced today that ... shares of its common stock at a price to ... granted to the underwriters a 30-day option to purchase ... to cover overallotments, if any. The offering is ... customary closing conditions. ,, J. P. Morgan Securities Inc. ...
(Date:12/10/2009)... Eye Institute (NEI), a division of the National Institutes of ... to help fund its development of a non-invasive, passive diffusion-based ... ... Salt Lake City, UT (PRWEB) December 10, ... the National Institutes of Health (NIH), awarded a $2.18 million ...
(Date:12/10/2009)... - YM BioSciences Inc. (NYSE Amex: YMI ... company that identifies and advances a diverse portfolio ... development, today provided an update on the proposed ... Cytopia Ltd. into YM, details of which were ... directors of Cytopia has unanimously recommended that its ...
(Date:12/10/2009)... Dec. 10 Vivakor, Inc. (OTC ... has entered into an exclusive, $5 million ... International, Inc. ( www.regeneca.com ). The ... to a new cutting-edge nutraceutical formulation developed ... of future formulations by Vivakor for Regeneca. ...
Breaking Biology Technology:Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3